Lupus Clinical Trials in Philadelphia

Showing 141-160 of 258 trials

Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty

NCT04590742

The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty

Sleep DisturbanceTotal Joint Arthroplasty

Rothman Institute Orthopaedics154 participantsStarted Feb 2018

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

NCT02349061

The purpose of this study is to evaluate the efficacy of ustekinumab as measured by a reduction in disease activity for subjects with active Active Systemic Lupus Erythematosus (SLE - chronic disorder of connective tissue in which there can be skin rash, arthritis, kidney problems, and anemia, among other problems).

Lupus Erythematosus, Systemic

Janssen Research & Development, LLC102 participantsStarted Oct 2015

Huntsville, Alabama, United States • Beverly Hills, California, United States • Tampa, Florida, United States +40 more locations

Randomized Trial Investigating Melatonin Supplementation vs Placebo on Sleep Disturbance Following Total Joint Arthroplasty

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Lupus Trials in Other Cities

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)

Telemedicine Management of Chronic Insomnia

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Association of Hypertensive Disorder of Pregnancy With Sleep-disordered Breathing.

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

Triptorelin for Ovary Protection in Childhood Onset Lupus

Rituximab and Belimumab for Lupus Nephritis

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)

Nelfinavir in Systemic Lupus Erythematosus

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

SNORE (Smartphone Analyses of Nocturnal Obstruction by Respiratory Evaluation) SOUNDS

Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Other Conditions in Philadelphia